Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation.
Kapelushnik
J
J
Department of Bone Marrow Transplantation, Hadassah University Hospital, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Or
R
R
Delukina
M
M
Nagler
A
A
Livni
N
N
Engelhard
D
D
D000258:Adenovirus Infections, Human / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000260:Adenoviruses, Human / Q000276:immunology / Q000302:isolation & purification; D000914:Antibodies, Viral / Q000032:analysis / Q000276:immunology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002675:Child, Preschool; D003106:Colon / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D005759:Gastroenteritis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007150:Immunohistochemistry; D007275:Injections, Intravenous; D008297:Male; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy
D000914:Antibodies, Viral; D000998:Antiviral Agents; D012254:Ribavirin